Skip to main content
Gustavo Rivero, MD, Oncology, Washington, DC, Ben Taub General Hospital

GustavoAdolfoRiveroMD

Oncology Washington, DC

Physician

Dr. Rivero is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rivero's full profile

Already have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
  • Cook County Health and Hospitals System
    Cook County Health and Hospitals SystemResidency, Internal Medicine, 2002 - 2005
  • Other
    OtherClass of 1994

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2008 - 2025
  • DC State Medical License
    DC State Medical License 2023 - 2024
  • VA State Medical License
    VA State Medical License 2023 - 2024
  • TX State Medical License
    TX State Medical License 2012 - 2024
  • FL State Medical License
    FL State Medical License 2005 - 2011
  • IL State Medical License
    IL State Medical License 2002 - 2005

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Superior Outcome in Elderly AML Patients Receiving Adjuvant Serotonin-Reuptake-Inhibitors during Induction
    Gustavo A. Rivero, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk Stratification
    Gustavo A. Rivero, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Predictive Factors for Complete Remission and Survival in AML Patients Failing to Achieve Adequate Bone Marrow Day 14 Blast Eradication 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Clinical Challenges: Optimizing Infection Prophylaxis in AML
    Clinical Challenges: Optimizing Infection Prophylaxis in AMLSeptember 15th, 2021
  • A Missed Opportunity in Expanded Access Limits Real-World Insights
    A Missed Opportunity in Expanded Access Limits Real-World InsightsJuly 7th, 2020

Hospital Affiliations